Physician profile
Peter E Ashman
NPI 1043745524
$1,297.79
in general payments reported to CMS, 2019-2025
17 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $161 · 2023: $314 · 2024: $347 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $332.44 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $257.22 | 2023-2025 | Dupixent |
| Aerin Medical INC. | $143.79 | 2025 | |
| Hikma Pharmaceuticals USA | $83.85 | 2023-2024 | Ryaltris |
| Harmony Biosciences LLC | $75.43 | 2022 | |
| Integra Lifesciences Corporation | $73.58 | 2024-2025 | Acclarent Aera, Relieva Spinplus Nav, Trudi Probe |
| Kaleo, INC. | $69.36 | 2023-2024 | Auvi-Q |
| Novartis Pharmaceuticals Corporation | $58.28 | 2025 | |
| Csl Behring | $33.12 | 2025 | Andembry |
| Jazz Pharmaceuticals INC. | $25.44 | 2022 | |
| Itamar Medical INC | $24.11 | 2022 | |
| Neurent Medical Limited | $23.44 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Inspire Medical Systems, INC. | $23.31 | 2024 | Inspire |
| Alk-Abello, INC | $22.92 | 2023 | Odactra, Ragwitek, Grastek |
| Stryker Corporation | $21.29 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.15 | 2022 | |
| Smith+Nephew, INC. | $15.06 | 2024 | Halo, Coblation, Tula |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ashman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.